Literature DB >> 17562998

Topical bevacizumab therapy for corneal neovascularization.

John J DeStafeno1, Terry Kim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562998     DOI: 10.1001/archopht.125.6.834

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  29 in total

Review 1.  Emerging techniques to treat corneal neovascularisation.

Authors:  J Menzel-Severing
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Corneal penetration of topical and subconjunctival bevacizumab.

Authors:  Mohammad H Dastjerdi; Zahra Sadrai; Daniel R Saban; Qiang Zhang; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

3.  Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization.

Authors:  Yoo C Kim; Hans E Grossniklaus; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-11       Impact factor: 4.799

4.  Efficacy of topical bevacizumab in high-risk corneal transplant survival.

Authors:  Nasir Bhatti; Umair Qidwai; Munawar Hussain; Asif Kazi
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

5.  Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.

Authors:  Jia Yin; Deborah S Jacobs
Journal:  Ocul Surf       Date:  2018-11-20       Impact factor: 5.033

6.  A case of ocular benign lymphoid hyperplasia treated with bevacizumab injection.

Authors:  Doo Hwan Oh; Yeoun Sook Chun; Jae Chan Kim
Journal:  Korean J Ophthalmol       Date:  2011-01-17

7.  Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization.

Authors:  Halil Ibrahim Onder; Mesut Erdurmus; Yasin Yücel Bucak; Hüseyin Simavli; Murat Oktay; Ahmet Sahap Kukner
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

8.  Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization.

Authors:  Young Sang Han; Ji Eun Lee; Ji Won Jung; Jong Soo Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-25       Impact factor: 3.117

9.  Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.

Authors:  Olga Dratviman-Storobinsky; Bat-Chen R Avraham-Lubin; Murat Hasanreisoglu; Nitza Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-11-13       Impact factor: 2.367

10.  Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization.

Authors:  Lingling Yang; Yao Wang; Qingjun Zhou; Peng Chen; Yiqiang Wang; Ye Wang; Ting Liu; Lixin Xie
Journal:  Mol Vis       Date:  2009-09-24       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.